Azitra, Inc.
AZTR- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001701478
No open-market purchases or sales by Azitra, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Azitra, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Azitra, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Salva Francisco D. | President and CEO | 4,086,291 | Jun 18, 2026 | 4 |
| Whitfill Travis | Chief Operating Officer | 334,500 | Apr 22, 2026 | 2 |
| Staskey Norm | Chief Financial Officer | 51,100 | Apr 22, 2026 | 2 |
| Schroer John R. | Director | – | Dec 22, 2025 | 1 |
| Ryan Barbara | Director | – | Dec 22, 2025 | 1 |
| Bayer Aktiengesellschaft | 10% Owner | 1,307,401 | Jul 24, 2023 | 0 |
| Bayer Healthcare LLC | 10% Owner | 1,307,401 | Jul 24, 2023 | 0 |
| Bayer World Investments B.V. | 10% Owner | 1,307,401 | Jul 24, 2023 | 0 |
| Bayer US Holding LP | 10% Owner | 1,307,401 | Jul 24, 2023 | 0 |
| McClary Andrew | Director | 291,911Indirect | Jun 29, 2023 | 0 |
| BIOS Fund I, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Fund I QP, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Fund II, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Fund II QP, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Fund II NT, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| Cavu Management, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| Cavu Advisors, LLC | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| Bios Equity Partners II, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| Bios Equity Partners, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| Kreis Leslie W. | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Azitra Co-Invest I, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| Fletcher Aaron G.L. | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Fund III NT, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Fund III QP, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Fund III, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Advisors GP, LLC | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Capital Management, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
| BIOS Equity Partners III, LP | 10% Owner | 436,173Indirect | Jun 23, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 (view filing) | Mar 18 | 2 days | Salva Francisco D.President and CEO | PPurchase | +12.2M | – | – | –4.06M after | Derivative3 lots |
| Apr 1, 2024 (view filing)9:51 PM ET | Mar 29 | 3 days | Staskey NormChief Financial Officer | PPurchase | +47.6K | $0.2108 | +$10.0K | +1,360.0%51.1K after | |
| Feb 15, 2024 (view filing)8:42 PM ET | Feb 13 | 2 days | Whitfill TravisChief Operating Officer | PPurchase | +15.0K | $0.30 | +$4.50K | +4.7%334.5K after | |
| Feb 15, 2024 (view filing)8:39 PM ET | Feb 13 | 2 days | Staskey NormChief Financial Officer | PPurchase | +3.30K | $0.30 | +$990 | +1,650.0%3.50K after | |
| Feb 15, 2024 (view filing)8:38 PM ET | Feb 13 | 2 days | Salva Francisco D.President and CEO | PPurchase | +333.3K | $0.30 | +$100.0K | +6,666.0%338.3K after | |
| Jun 23, 2023 (view filing)9:38 PM ET | Jun 21 | 2 days | BIOS Fund I, LP and 9 others10% Owner | SSaleConvertible Notes | −669.3K | – | – | −100.0%0 after | 3 lotsDuplicate filing |
| Jun 23, 2023 (view filing)9:38 PM ET | Jun 21 | 2 days | BIOS Fund I, LP and 9 others10% Owner | PPurchase | +2.30M | $5.00 | +$3.00M | New position282.2K after | 6 lotsDuplicate filing |
| Jun 23, 2023 (view filing)9:37 PM ET | Jun 21 | 2 days | BIOS Azitra Co-Invest I, LP and 7 others10% Owner | SSaleConvertible Notes | −669.3K | – | – | −100.0%0 after | 3 lots |
| Jun 23, 2023 (view filing)9:37 PM ET | Jun 21 | 2 days | BIOS Azitra Co-Invest I, LP and 7 others10% Owner | PPurchase | +2.30M | $5.00 | +$3.00M | New position282.2K after | 6 lots |